Eris Lifesciences Gets Brazil Health Nod
x
Eris Lifesciences unit in Ahmedabad receives approval from Brazil's ANVISA, enabling entry into the largest South American pharma market.
New Delhi, Aug 25 (PTI) Eris Lifesciences on Monday said one of its manufacturing units in Ahmedabad has received approval from Brazil's national health regulatory agency ANVISA.
The approval follows a successful inspection conducted by the agency in May 2025, and enables the drugmaker to enter Brazil, the largest pharmaceutical market in South America, Eris Lifesciences said in a statement.
Shares of the company were trading 0.2 per cent up at Rs 1,772.50 apiece on BSE.
The approval follows a successful inspection conducted by the agency in May 2025, and enables the drugmaker to enter Brazil, the largest pharmaceutical market in South America, Eris Lifesciences said in a statement.
Shares of the company were trading 0.2 per cent up at Rs 1,772.50 apiece on BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Billionbrains Garage
- 188.82 (+ 8.04)
- 77986429
- Vodafone Idea L
- 10.74 ( -1.83)
- 63105249
- Spright Agro
- 0.56 (+ 3.70)
- 52174708
- Sunshine Capital
- 0.27 (+ 3.85)
- 30062255
- MphasiS Ltd.
- 2,659.70 ( -1.10)
- 19196704
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback